Gemcitabine and malignant neoplasm progression Patient Reports February 11, 2012

Gemcitabine Side Effects Report #5563712-2
Gemcitabine side effect was reported by a Physician from JAPAN on Dec 10, 2007. Male patient, weighting 102.5 lb, was diagnosed with pleural mesothelioma malignant and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome. Gemcitabine dosage: 900 MG/M2, OTHER. Patient was hospitalized. Patient died on 12/07/2007.

Gemcitabine Side Effects Report #5581867-0
Gemcitabine side effect was reported by a Physician from JAPAN on Dec 27, 2007. Male patient, weighting 97.00 lb, was diagnosed with pleural mesothelioma malignant, prophylaxis, reflux oesophagitis and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome. Gemcitabine dosage: 600 MG/M2, OTHER. During the same period patient was treated with CARBOPLATIN, KYTRIL, DECADRON, TAKEPRON. Patient died on 12/07/2007.

Gemcitabine Side Effects Report #5604533-1
Gemcitabine side effect was reported by a Physician from JAPAN on Jan 17, 2008. Male patient, weighting 97.00 lb, was diagnosed with pleural mesothelioma malignant, prophylaxis, reflux oesophagitis and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: infection , malignant neoplasm progression, myelodysplastic syndrome. Gemcitabine dosage: 600 MG/M2, OTHER. During the same period patient was treated with CARBOPLATIN, KYTRIL, DECADRON, TAKEPRON. Patient died on 12/07/2007.

Gemcitabine Side Effects Report #5697139-X
Gemcitabine side effect was reported by a Physician from JAPAN on Mar 27, 2008. Male patient, weighting 97.00 lb, was diagnosed with pleural mesothelioma malignant, prophylaxis, reflux oesophagitis and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: infection , malignant neoplasm progression, myelodysplastic syndrome. Gemcitabine dosage: 600 MG/M2, OTHER. During the same period patient was treated with CARBOPLATIN, KYTRIL, DECADRON, TAKEPRON. Patient died on 12/07/2007.


Gemcitabine Side Effects Report #5422553-7
Gemcitabine side effect was reported by a Physician from JAPAN on Aug 16, 2007. Female patient, 67 years of age, weighting 99.21 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: gastrointestinal perforation, malignant ascites, malignant neoplasm progression, subileus. Gemcitabine dosage: 1000 MG/M2, OTHER. Patient was hospitalized. Patient died on 02/16/2007.

Gemcitabine Side Effects Report #6016254-4
Gemcitabine side effect was reported by a Physician from JAPAN on Dec 16, 2008. Female patient, weighting 93.04 lb, was diagnosed with pancreatic carcinoma non-resectable, cancer pain, prophylaxis, prophylaxis of nausea and vomiting and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: inappropriate antidiuretic hormone secretion, malignant neoplasm progression. Gemcitabine dosage: 1000 MG/M2, OTHER. During the same period patient was treated with LOXOPROFEN, RABEPRAZOLE, DEXART, GRANISETRON. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5607372-0
Gemcitabine side effect was reported by a Physician from FRANCE on Jan 18, 2008. Female patient, 60 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: capillary leak syndrome, malignant neoplasm progression, renal failure. Gemcitabine dosage: 1000 MG/M2, WEEKLY (1/W). Patient was hospitalized. Patient died.

Gemcitabine Side Effects Report #4548745-7
Gemcitabine side effect was reported by a Health Professional from on Jan 07, 2005. Female patient, 82 years of age, weighting 120.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: cerebral ischaemia, incoherent, malignant neoplasm progression, metastases to central nervous system, transient ischaemic attack. Gemcitabine dosage: 185MG Q2 WEEKS INTRAVENOUS. During the same period patient was treated with IRINOTECAN, DURAGESIC, FOSFOMAX, VIOKASE, COUMADIN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5235376-9
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Feb 08, 2007. Female patient, 72 years of age, weighting 96.60 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pancreatic carcinoma. Gemcitabine dosage: 1000MG/M2 D 1,8,15 Q 28 D IV DRIP. During the same period patient was treated with ERLOTINIB. Patient died on 01/26/2007.


Gemcitabine Side Effects Report #5289263-0
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Apr 03, 2007. Male patient, 69 years of age, weighting 173.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, malignant neoplasm progression, pain , pancreatic carcinoma. Gemcitabine dosage: 1000MG/M2 D 1, 8, 15 IV DRIP. During the same period patient was treated with NOVASOY, ERLOTINIB. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #6108107-8
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Mar 05, 2009. Female patient, 63 years of age, weighting 123.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain , adenocarcinoma, asthenia, decreased appetite, dehydration, fatigue, malignant neoplasm progression, metastases to liver, metastatic neoplasm. Gemcitabine dosage: unknown. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5158332-8
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Nov 21, 2006. Male patient, weighting 137.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: ascites, deep vein thrombosis , dehydration, malignant neoplasm progression, pancreatic carcinoma metastatic. Gemcitabine dosage: 1000MG/M2 DAY 1 + 15 IV DRIP. During the same period patient was treated with CISPLATIN, BEVACIZUMAB, MS CONTIN, DILAUDID, METOPROLOL SUCCINATE, COUMADIN, MIRALAX. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4677610-X
Gemcitabine side effect was reported by a Consumer or non-health professional from on May 27, 2005. Male patient, weighting 259.5 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: fatigue, malignant neoplasm progression, pancreatic carcinoma, performance status decreased, somnolence. Gemcitabine dosage: 1500 MG/M2 IV OVER 150 MIN. Q WK. X3 EVERY 4 WEEKS. Patient recovered.

Gemcitabine Side Effects Report #4687882-3
Gemcitabine side effect was reported by a Consumer or non-health professional from on June 08, 2005. Female patient, weighting 129.8 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: ascites, blood pressure diastolic decreased, gastrointestinal ulcer, intestinal ischaemia, intestinal obstruction, loss of consciousness, malignant neoplasm progression, ovarian cyst , respiratory rate increased. Gemcitabine dosage: 1000 MG/M2: THE FIRST TREATMENT CONSISTED OF WEEKLY TREATMENTS FOR FOUR WEEKS. ALL SUBSEQUENT TREAT. Patient recovered.


Gemcitabine Side Effects Report #4691793-7
Gemcitabine side effect was reported by a Consumer or non-health professional from on June 15, 2005. Female patient, weighting 143.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: blood count abnormal, hepatic failure, loss of consciousness, malignant neoplasm progression, respiratory distress, stent occlusion. Gemcitabine dosage: 1000 MG/M2 IV OVER 30 MIN Q WK X 7. Patient died on 06/12/2005.

Gemcitabine Side Effects Report #4731475-6
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2005. Male patient, weighting 139.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to liver. Gemcitabine dosage: unknown. Patient died on 07/13/2005.

Gemcitabine Side Effects Report #4752188-0
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2005. Male patient, weighting 138.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: infection , lower gastrointestinal haemorrhage, malignant neoplasm progression, nausea , neutrophil count abnormal, pain . Gemcitabine dosage: unknown. Patient was hospitalized. Patient died on 08/20/2005.

Gemcitabine Side Effects Report #4752249-6
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2005. Male patient, weighting 138.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: lower gastrointestinal haemorrhage, malignant neoplasm progression, pain , post procedural nausea. Gemcitabine dosage: unknown. Patient recovered.

Gemcitabine Side Effects Report #4822648-2
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 07, 2005. Female patient, weighting 127.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pancreatic carcinoma metastatic, small intestinal obstruction. Gemcitabine dosage: unknown. Patient was hospitalized. Patient died on 10/27/2005.


Gemcitabine Side Effects Report #4859695-0
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 15, 2005. Female patient, weighting 238.1 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abasia, adrenal mass, asthenia, dysstasia, hepatic mass, lymphadenopathy, malignant neoplasm progression, muscle mass, pancreatic fistula. Gemcitabine dosage: unknown. Patient died on 12/12/2005.

Gemcitabine Side Effects Report #4546643-6
Gemcitabine side effect was reported by a Physician from on Dec 09, 2004. Female patient, 65 years of age, was diagnosed with ovarian cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: ileal perforation, ileus paralytic, malignant neoplasm progression, metastatic neoplasm. Gemcitabine dosage: 1100 MG/2 OTHER. During the same period patient was treated with DOXORUBICIN, INTERFERON GAMMA, CARBOPLATIN, PACLITAXEL, INDAPAMIDE. Patient was hospitalized. Patient died on 04/17/2004.

Gemcitabine Side Effects Report #4698478-1
Gemcitabine side effect was reported by a Physician from on June 03, 2005. Female patient, 64 years of age, was diagnosed with oesophageal cancer metastatic and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, oesophageal cancer metastatic, pneumonitis, recall phenomenon. Gemcitabine dosage: 1000 MG/M2. During the same period patient was treated with DOCETAXEL. Patient recovered.

Gemcitabine Side Effects Report #4629886-2
Gemcitabine side effect was reported by a Physician from on Mar 18, 2005. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: confusional state, malignant neoplasm progression, non-small cell lung cancer. Gemcitabine dosage: 1800 MG. During the same period patient was treated with METOCLOPRAMIDE, ZOLEDRONIC ACID. Patient was hospitalized. Patient died on 02/18/2005.

Gemcitabine Side Effects Report #5097603-0
Gemcitabine side effect was reported by a Consumer or non-health professional from PAKISTAN on Aug 15, 2006. Male patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dyspnoea, febrile neutropenia, infection , malignant neoplasm progression. Gemcitabine dosage: 1400 MG, INTRAVENOUS. Patient was hospitalized. Patient died.


Gemcitabine Side Effects Report #4823828-2
Gemcitabine side effect was reported by a Physician from SLOVENIA on Oct 25, 2005. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: cerebral ischaemia, malignant neoplasm progression. Gemcitabine dosage: 130 MG/M2 OTHER. During the same period patient was treated with CISPLATIN. Patient died.

Gemcitabine Side Effects Report #5828580-X
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on July 29, 2008. Male patient, 63 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: carotid artery occlusion, cerebral infarction, lung neoplasm malignant, malignant neoplasm progression. Gemcitabine dosage: 1940 MG IV. During the same period patient was treated with DOCETAXEL, CETUXIMAB. Patient recovered.

Gemcitabine Side Effects Report #4693892-2
Gemcitabine side effect was reported by a Physician from on May 31, 2005. Male patient, 50 years of age, weighting 174.2 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dermatitis allergic, lung neoplasm malignant, malignant neoplasm progression, rash . Gemcitabine dosage: 2280 MG/2 OTHER. During the same period patient was treated with CARBOPLATIN, NAVELBINE, ONDANSETRON, DEXAMETHASONE. Patient was hospitalized. Patient died.

Gemcitabine Side Effects Report #6028298-7
Gemcitabine side effect was reported by a Physician from INDIA on Jan 02, 2009. Male patient was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: full blood count decreased, malignant neoplasm progression. Gemcitabine dosage: unknown. Patient was hospitalized. Patient died.

Gemcitabine Side Effects Report #5796186-7
Gemcitabine side effect was reported by a Physician from ITALY on June 17, 2008. Male patient, 67 years of age, was diagnosed with lung neoplasm malignant, adrenal insufficiency and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, strongyloidiasis. Gemcitabine dosage: unknown. During the same period patient was treated with CISPLATIN, ZOLEDRONIC ACID, CORTISONE ACETATE, DEXAMETHASONE. Patient died.


Gemcitabine Side Effects Report #5636497-9
Gemcitabine side effect was reported by a Physician from JAPAN on Feb 14, 2008. Male patient, weighting 138.9 lb, was diagnosed with lung adenocarcinoma stage ii, radiation pneumonitis and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome, radiation pneumonitis. Gemcitabine dosage: 1000 MG/M2, OTHER. During the same period patient was treated with PREDONINE. Patient recovered.

Gemcitabine Side Effects Report #5690268-6
Gemcitabine side effect was reported by a Physician from JAPAN on Mar 19, 2008. Male patient, weighting 138.9 lb, was diagnosed with lung adenocarcinoma stage ii, radiation pneumonitis and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome, radiation pneumonitis. Gemcitabine dosage: 1000 MG/M2, OTHER. During the same period patient was treated with PREDONINE. Patient recovered.

Gemcitabine Side Effects Report #5732800-X
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on May 07, 2008. Male patient, 73 years of age, weighting 140.0 lb, was diagnosed with head and neck cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: dyspnoea, head and neck cancer , malignant neoplasm progression. Gemcitabine dosage: 1500 MG/M2 EVERY 14 DAYS IV. During the same period patient was treated with PEMETREXED, SENNA, SYTHROID, MIRALAX, ROXICET, MAGIC MOUTHWASH, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #4686984-5
Gemcitabine side effect was reported by a Physician from on May 20, 2005. Male patient, 35 years of age, was diagnosed with germ cell cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia, malignant neoplasm progression, neurotoxicity, thrombocytopenia. Gemcitabine dosage: 800 MG/M2 OTHER. During the same period patient was treated with PACLITAXEL, OXALIPLATIN, DEXAMETHASONE, ORPHENADRINE, CIMETIDINE. Patient died.

Gemcitabine Side Effects Report #5151742-4
Gemcitabine side effect was reported by a Physician from SINGAPORE on Oct 20, 2006. Male patient, 59 years of age, weighting 145.3 lb, was diagnosed with colon cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pneumonitis, weight decreased. Gemcitabine dosage: 800 MG INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, DEXAMETHASONE, CAELYX, KYTRIL. Patient was hospitalized. Patient died on 07/19/2006.


Gemcitabine Side Effects Report #5968308-6
Gemcitabine side effect was reported by a Physician from UNITED STATES on Nov 17, 2008. Male patient, 72 years of age, was diagnosed with bladder cancer  and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, bronchospasm, capillary leak syndrome, circulatory collapse, interstitial lung disease, malignant neoplasm progression. Gemcitabine dosage: 1250 MG/M2, UNK (ON D1 AND D8 FOR THREE WEEKLY CYCLES. During the same period patient was treated with CISPLATIN, ATENOLOL, ACETYLSALICYLIC ACID SRT, METFORMIN, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5318163-2
Gemcitabine side effect was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, 78 years of age, weighting 114.6 lb, was diagnosed with bile duct cancer recurrent, prophylaxis, cholangitis and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: anastomotic ulcer, bile duct cancer, malignant neoplasm progression. Gemcitabine dosage: 1500 MG, OTHER. During the same period patient was treated with KYTRIL, SWORD. Patient was hospitalized. Patient recovered.

Gemcitabine Side Effects Report #5716021-2
Gemcitabine side effect was reported by a Physician from JAPAN on Apr 16, 2008. Female patient, weighting 110.2 lb, was diagnosed with bile duct cancer, hepatitis b , pain , gastritis, prophylaxis and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, malignant neoplasm progression, pneumonia , pulmonary embolism , tumour lysis syndrome. Gemcitabine dosage: 1460 MG, UNK. During the same period patient was treated with ANTIVIRALS NOS, LOXONIN, MUCOSTA, NOVAMIN, MAGMITT, OXYCONTIN, OMEPRAL. Patient died on 03/25/2008.

Gemcitabine Side Effects Report #4546637-0
Gemcitabine side effect was reported by a Physician from on Dec 20, 2004. Male patient, 71 years of age, was diagnosed with adenosquamous cell lung cancer stage iv and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: aphasia , confusional state, infusion related reaction, malignant neoplasm progression, myoclonic epilepsy. Gemcitabine dosage: 1000 MG/M2; OTHER. During the same period patient was treated with CISPLATIN, ONDANSETRON, PREDNISOLONE, METOCLOPRAMIDE. Patient died.

Gemcitabine Side Effects Report #5607370-7
Gemcitabine side effect was reported by a Physician from FRANCE on Jan 18, 2008. Male patient, 68 years of age, was diagnosed with adenocarcinoma pancreas and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: capillary leak syndrome, malignant neoplasm progression, neutropenia, renal failure. Gemcitabine dosage: 1000 MG/M2, WEEKLY (1/W). Patient died.


Gemcitabine Side Effects Report #5298983-3
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Apr 12, 2007. Male patient, 69 years of age, weighting 173.0 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pain , pancreatic carcinoma. Gemcitabine dosage: 1000MG/M2 D 1,8,15 IV DRIP. During the same period patient was treated with NOVASOY. Patient was hospitalized. Patient died on 04/08/2007.

Gemcitabine Side Effects Report #4590281-6
Gemcitabine side effect was reported by a Health Professional from on Feb 18, 2005. Male patient, weighting 150.0 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: intestinal obstruction, malignant neoplasm progression, pancreatic carcinoma. Gemcitabine dosage: 1000 MG M2 IV, DAYS 1,8,15 Q 4 WKS AFTER LOADING DOSE 1000 MG M2 IV WKLY X 7 WKS. Patient died on 12/25/2004.